Latest news with #GPI
Yahoo
3 days ago
- Automotive
- Yahoo
Why Group 1 Automotive (GPI) is Poised to Beat Earnings Estimates Again
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Group 1 Automotive (GPI). This company, which is in the Zacks Automotive - Retail and Whole Sales industry, shows potential for another earnings beat. This auto dealer has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 6.93%. For the most recent quarter, Group 1 Automotive was expected to post earnings of $10.17 per share, but it reported $9.68 per share instead, representing a surprise of 5.06%. For the previous quarter, the consensus estimate was $9.21 per share, while it actually produced $10.02 per share, a surprise of 8.79%. Price and EPS Surprise Thanks in part to this history, there has been a favorable change in earnings estimates for Group 1 Automotive lately. In fact, the Zacks Earnings ESP (Expected Surprise Prediction) for the stock is positive, which is a great indicator of an earnings beat, particularly when combined with its solid Zacks Rank. Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Group 1 Automotive has an Earnings ESP of +7.25% at the moment, suggesting that analysts have grown bullish on its near-term earnings potential. When you combine this positive Earnings ESP with the stock's Zacks Rank #1 (Strong Buy), it shows that another beat is possibly around the corner. The company's next earnings report is expected to be released on July 24, 2025. With the Earnings ESP metric, it's important to note that a negative value reduces its predictive power; however, a negative Earnings ESP does not indicate an earnings miss. Many companies end up beating the consensus EPS estimate, but that may not be the sole basis for their stocks moving higher. On the other hand, some stocks may hold their ground even if they end up missing the consensus estimate. Because of this, it's really important to check a company's Earnings ESP ahead of its quarterly release to increase the odds of success. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Group 1 Automotive, Inc. (GPI) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
4 days ago
- Business
- Reuters
KKR mulls acquisition of healthcare technology firm GPI, Bloomberg News reports
July 16 (Reuters) - KKR (KKR.N), opens new tab is considering a potential buyout of Italian health-care technology firm GPI SpA ( opens new tab, as the U.S. investment firm scouts for takeover targets amid the recent market volatility, Bloomberg News reported on Wednesday. KKR has been in talks with advisers in recent weeks as it considers a potential deal to take Trento-based GPI private, the report said, citing people with knowledge of the matter. The report added that the discussions might not lead to a transaction. KKR declined to comment, while GPI did not immediately respond when contacted by Reuters. An investment company backed by GPI Chief Executive Officer Fausto Manzana is the company's biggest shareholder, with a 48% stake, equivalent to 57.3% of the voting rights, according to GPI's website. Europe is "a very interesting place to invest," Henry Kravis, KKR's co-founder told Bloomberg in an interview in May. KKR has invested about $30 billion since the start of the year, about half of that offshore. British scientific instruments maker Spectris (SXS.L), opens new tab earlier this month agreed to a takeover offer from KKR, valuing it at 4.7 billion pounds ($6.31 billion). ($1 = 0.7452 pounds)
Bloomberg
4 days ago
- Business
- Bloomberg
KKR Mulls Acquisition of Health-Care Technology Firm GPI
KKR & Co., the buyout firm that's been scouting for takeover targets amid the recent market volatility, is considering a potential acquisition of Italian health-care technology firm GPI SpA, according to people with knowledge of the matter. The US private equity firm has been speaking with advisers in recent weeks as it considers a potential deal to take Trent-based GPI private, the people said, asking not to be identified as the matter is private. Shares of GPI have risen 24% in Milan trading this year, giving the company a market value of about €377 million ($438 million).
Scientific American
5 days ago
- Health
- Scientific American
Doctors Discover a Woman With Her Own Unique Blood Type
The following essay is reprinted with permission from The Conversation, an online publication covering the latest research. In a routine blood test that turned extraordinary, French scientists have identified the world's newest and rarest blood group. The sole known carrier is a woman from Guadeloupe whose blood is so unique that doctors couldn't find a single compatible donor. The discovery of the 48th recognised blood group, called 'Gwada-negative', began when the woman's blood plasma reacted against every potential donor sample tested, including those from her own siblings. Consequently, it was impossible to find a suitable blood donor for her. On supporting science journalism If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today. Many people know their blood type – A, B, AB or O – along with whether they are Rh-positive or negative. But these familiar categories (those letters plus 'positive' or 'negative') represent just two of several dozens of blood group systems that determine compatibility for transfusions. Each system reflects subtle but crucial differences in the proteins and sugars coating our red blood cells. To solve the mystery of the Guadeloupian woman's incompatible blood, scientists turned to cutting-edge genetic analysis. Using whole exome sequencing – a technique that examines all 20,000-plus human genes – they discovered a mutation in a gene called PIGZ. This gene produces an enzyme responsible for adding a specific sugar to an important molecule on cell membranes. The missing sugar changes the structure of a molecule on the surface of red blood cells. This change creates a new antigen – a key feature that defines a blood group – resulting in an entirely new classification: Gwada-positive (having the antigen) or -negative (lacking it). Using gene editing technology, the team confirmed their discovery by recreating the mutation in a lab. So red blood cells from all blood donors tested are Gwada-positive and the Guadeloupean patient is the only known Gwada-negative person on the planet. The implications of the discovery extend beyond blood transfusions. The patient suffers from mild intellectual disability, and tragically, she lost two babies at birth – outcomes that may be connected to her rare genetic mutation. The enzyme produced by the PIGZ gene operates at the final stage of building a complex molecule called GPI (glycosylphosphatidylinositol). Previous research has shown that people with defects in other enzymes needed for GPI assembly can experience neurological problems ranging from developmental delays to seizures. Stillbirths are also common among women with these inherited disorders. Although the Caribbean patient is the only person in the world so far with this rare blood type, neurological conditions including developmental delay, intellectual disability and seizures have been noted in other people with defects in enzymes needed earlier in the GPI assembly line. The Gwada discovery highlights both the marvels and challenges of human genetic diversity. Blood groups evolved partly as protection against infectious diseases (many bacteria, viruses and parasites use blood group molecules as entry points into cells). This means your blood type can influence your susceptibility to certain diseases. But extreme rarity creates medical dilemmas. The French researchers acknowledge they cannot predict what would happen if Gwada-incompatible blood were transfused into the Guadeloupian woman. Even if other Gwada-negative people exist, they would be extremely difficult to locate. It is also unclear if they can become blood donors. This reality points towards a futuristic solution: lab-grown blood cells. Scientists are already working on growing red blood cells from stem cells that could be genetically modified to match ultra-rare blood types. In the case of Gwada, researchers could artificially create Gwada-negative red blood cells by mutating the PIGZ gene. A growing field Gwada joins 47 other blood group systems recognised by the International Society of Blood Transfusion. Like most of these blood-group systems, it was discovered in a hospital lab where technicians were trying to find compatible blood for a patient. The name reflects the case's Caribbean roots: Gwada is slang for someone from Guadeloupe, giving this blood group both scientific relevance and cultural resonance. As genetic sequencing becomes more advanced and widely used, researchers expect to uncover more rare blood types. Each discovery expands our understanding of human variation and raises fresh challenges for transfusion and other types of personalised medicine.
Yahoo
11-07-2025
- Automotive
- Yahoo
Group 1 Automotive (GPI) Soars 3.1%: Is Further Upside Left in the Stock?
Group 1 Automotive (GPI) shares rallied 3.1% in the last trading session to close at $480.13. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 5.2% gain over the past four weeks. Group 1's shares surged, driven by the company's effort to expand and optimize its portfolio through acquisitions of dealerships and franchises. In 2024, the company closed the Inchcape buyout, which is expected to add $2.7 billion in annualized revenues. Total acquired revenues in 2024 reached $3.9 billion. Year to date, GPI has acquired $430 million in annualized revenues. This auto dealer is expected to post quarterly earnings of $10.16 per share in its upcoming report, which represents a year-over-year change of +3.7%. Revenues are expected to be $5.51 billion, up 17.3% from the year-ago quarter. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. For Group 1 Automotive, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on GPI going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Group 1 Automotive is part of the Zacks Automotive - Retail and Whole Sales industry. AutoNation (AN), another stock in the same industry, closed the last trading session 0.7% higher at $214.83. AN has returned 9.8% in the past month. For AutoNation, the consensus EPS estimate for the upcoming report has changed +0.7% over the past month to $4.62. This represents a change of +15.8% from what the company reported a year ago. AutoNation currently has a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Group 1 Automotive, Inc. (GPI) : Free Stock Analysis Report AutoNation, Inc. (AN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
